1. Home
  2. BCYC vs NPFD Comparison

BCYC vs NPFD Comparison

Compare BCYC & NPFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • NPFD
  • Stock Information
  • Founded
  • BCYC 2009
  • NPFD 2021
  • Country
  • BCYC United Kingdom
  • NPFD United States
  • Employees
  • BCYC N/A
  • NPFD N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • NPFD Trusts Except Educational Religious and Charitable
  • Sector
  • BCYC Health Care
  • NPFD Finance
  • Exchange
  • BCYC Nasdaq
  • NPFD Nasdaq
  • Market Cap
  • BCYC 566.5M
  • NPFD 462.7M
  • IPO Year
  • BCYC 2019
  • NPFD N/A
  • Fundamental
  • Price
  • BCYC $7.42
  • NPFD $18.99
  • Analyst Decision
  • BCYC Buy
  • NPFD
  • Analyst Count
  • BCYC 10
  • NPFD 0
  • Target Price
  • BCYC $25.00
  • NPFD N/A
  • AVG Volume (30 Days)
  • BCYC 223.0K
  • NPFD 64.7K
  • Earning Date
  • BCYC 08-05-2025
  • NPFD 01-01-0001
  • Dividend Yield
  • BCYC N/A
  • NPFD 6.28%
  • EPS Growth
  • BCYC N/A
  • NPFD N/A
  • EPS
  • BCYC N/A
  • NPFD N/A
  • Revenue
  • BCYC $25,722,000.00
  • NPFD N/A
  • Revenue This Year
  • BCYC $7.35
  • NPFD N/A
  • Revenue Next Year
  • BCYC N/A
  • NPFD N/A
  • P/E Ratio
  • BCYC N/A
  • NPFD N/A
  • Revenue Growth
  • BCYC N/A
  • NPFD N/A
  • 52 Week Low
  • BCYC $6.10
  • NPFD $14.50
  • 52 Week High
  • BCYC $28.67
  • NPFD $18.07
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 36.14
  • NPFD 54.58
  • Support Level
  • BCYC $8.33
  • NPFD $18.74
  • Resistance Level
  • BCYC $8.63
  • NPFD $19.18
  • Average True Range (ATR)
  • BCYC 0.50
  • NPFD 0.19
  • MACD
  • BCYC -0.13
  • NPFD -0.02
  • Stochastic Oscillator
  • BCYC 7.18
  • NPFD 55.26

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About NPFD Nuveen Variable Rate Preferred & Income Fund

Nuveen Variable Rate Preferred&Income is a newly organized, diversified, closed-end management investment company. The Fund's investment objective is to seek to provide a high level of current income and total return.

Share on Social Networks: